Citation Impact
Citing Papers
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
2020 StandoutScience
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Transmission routes of 2019-nCoV and controls in dental practice
2020 Standout
Health care-associated infections – an overview
2018 Standout
Face mask and medical waste disposal during the novel COVID-19 pandemic in Asia
2020 Standout
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
2011
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species
2010
Generation of a Cell Culture-Adapted Hepatitis C Virus with Longer Half Life at Physiological Temperature
2011
Possible aerosol transmission of COVID-19 and special precautions in dentistry
2020 Standout
Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature
2011
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
2020 Standout
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes
2015 StandoutNobel
Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
2010
Coronaviruses: An Overview of Their Replication and Pathogenesis
2015 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care
2020 Standout
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
2020 Standout
Interferon-stimulated genes and their antiviral effector functions
2011 StandoutNobel
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
2011 StandoutNobel
A Review of Coronavirus Disease-2019 (COVID-19)
2020 Standout
Entry and replication of recombinant hepatitis C viruses in cell culture
2012
COVID-19 and Living space challenge. Well-being and Public Health recommendations for a healthy, safe, and sustainable housing.
2020 Standout
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Stable Growth of Wild-Type Hepatitis A Virus in Cell Culture
2006
COVID-19 and Cities: from Urban Health strategies to the pandemic challenge. A Decalogue of Public Health opportunities.
2020 Standout
(In)Segurança alimentar no contexto da pandemia por SARS-CoV-2
2020 Standout
Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection
2005
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Works of Britta Becker being referenced
How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV and Its Susceptibility to Chemical Biocides
2010
Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
2017
Inactivation of murine norovirus by chemical biocides on stainless steel
2009
Hepatitis A Virus Suppresses Monocyte-to-Macrophage Maturation In Vitro
2002